恒生医药ETF华夏(159892)资产负债表
| |
2026-06-30 |
2025-12-31 |
2025-06-30 |
2024-12-31 |
| 资产 |
| 银行存款 |
- |
- |
- |
- |
| 结算备付金 |
69,920,343.89 |
41,297,070.34 |
39,689,751.42 |
126,732.27 |
| 存出保证金 |
15,597,498.02 |
10,051,918.85 |
- |
- |
| 交易性金融资产 |
4,308,520,693.81 |
5,497,872,035.41 |
4,287,701,799.90 |
4,149,817,838.09 |
| 其中:股票投资 |
4,168,687,531.15 |
5,374,870,180.98 |
4,206,196,815.82 |
4,149,817,838.09 |
| 债券投资 |
- |
- |
- |
- |
| 资产支持证券投资 |
- |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
- |
| 应收证券清算款 |
170,898,283.71 |
14,274,828.73 |
30,441.00 |
- |
| 应收利息 |
- |
- |
- |
- |
| 应收股利 |
13,140,757.08 |
344,433.86 |
11,644,942.15 |
- |
| 应收申购款 |
- |
- |
- |
- |
| 其他资产 |
- |
- |
- |
- |
| 资产总计 |
4,641,505,832.88 |
5,620,571,011.36 |
4,551,983,593.93 |
4,166,717,258.33 |
| 负 债 |
| 短期借款 |
- |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
- |
| 应付证券清算款 |
53,573.48 |
9,570,619.35 |
183,763,904.61 |
3,578.11 |
| 应付赎回款 |
- |
- |
- |
- |
| 应付管理人报酬 |
1,860,059.03 |
2,455,796.06 |
1,721,371.38 |
1,788,874.79 |
| 应付托管费 |
574,631.73 |
753,409.73 |
524,764.97 |
536,662.43 |
| 应付销售服务费 |
- |
- |
- |
- |
| 应付交易费用 |
- |
- |
- |
- |
| 应交税费 |
- |
- |
- |
- |
| 应付利息 |
- |
- |
- |
- |
| 应付利润 |
- |
- |
- |
- |
| 其他负债 |
226,958,113.54 |
43,122,219.74 |
61,054,998.79 |
619,540.54 |
| 负债合计 |
229,446,377.78 |
55,902,044.88 |
247,065,039.75 |
2,948,655.87 |
| 所有者权益 |
| 实收基金 |
6,710,266,022.00 |
7,263,266,022.00 |
5,933,266,022.00 |
8,690,266,022.00 |
| 未分配利润 |
-2,298,206,566.90 |
-1,698,597,055.52 |
-1,628,347,467.82 |
-4,526,497,419.54 |
| 所有者权益合计 |
4,412,059,455.10 |
5,564,668,966.48 |
4,304,918,554.18 |
4,163,768,602.46 |
| 负债及所有者权益总计 |
4,641,505,832.88 |
5,620,571,011.36 |
4,551,983,593.93 |
4,166,717,258.33 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年